-
Serum neurofilaments as candidate biomarkers of natalizumab associated progressive multifocal leukoencephalopathy
Loonstra, F. C., Verberk, I. M. W., Wijburg, M. T., Wattjes, M. P., Teunissen, C. E., van Oosten, B. W., Uitdehaag, B. M. J., Killestein, J. & van Kempen, Z. L. E., 1 Aug 2019, In: Annals of neurology. 86, 2, p. 322-324 3 p.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance
Wijburg, M. T., Witte, B. I., Vennegoor, A., Roosendaal, S. D., Sanchez, E., Liu, Y., Martins Jarnalo, C. O., Uitdehaag, B. M. J., Barkhof, F., Killestein, J. & Wattjes, M. P., Oct 2016, In: Journal of neurology, neurosurgery, and psychiatry. 87, 10, p. 1138-1145Research output: Contribution to journal › Article* › Academic › peer-review
-
Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients
Wattjes, M. P., Wijburg, M. T., Vennegoor, A., Witte, B. I., Roosendaal, S. D., Sanchez, E., Liu, Y., Martins Jarnalo, C. O., Richert, N. D., Uitdehaag, B. M. J., Barkhof, F. & Killestein, J., Aug 2016, In: Multiple sclerosis (Houndmills, Basingstoke, England). 22, 9, p. 1174-1183Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
